Anteris Technologies Global (AVR) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anteris Technologies Global (AVR) has outperformed Sanara MedTech (SMTI) over the past year, gaining 38.7% versus a gain of 8.4%. Anteris Technologies Global is the larger company by market cap ($658.8 million vs $322.1 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVR | SMTI |
|---|---|---|
| Share price | $6.76 | $35.06 |
| Market cap | $658.82M | $322.09M |
| 1-day change | +1.96% | +0.01% |
| YTD return | +32.87% | +50.11% |
| 1-year return | +38.70% | +8.41% |
| 5-year return | — | +6.28% |
| Forward P/E | — | 64.92 |
| EPS (TTM) | $-1.95 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.06 | $35.34 |
| 52-week low | $3.30 | $16.05 |
| Distance from 52-week high | -38.85% | -0.81% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +107.10% | -0.16% |
| Average volume | 935.07K | 280.40K |
| Shares outstanding | 97.46M | 9.19M |
| Employees | 174 | 108 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Anteris Technologies Global is about 2.0 times larger than Sanara MedTech by market value ($658.82M vs $322.09M).
- AVR has outperformed SMTI by 30.3 percentage points over the past year.
About Anteris Technologies Global
AVR stock →Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
Health Care · Industrial Specialties · 174 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
AVR vs SMTI FAQ
Which is bigger, Anteris Technologies Global or Sanara MedTech?
Anteris Technologies Global (AVR) is larger, with a market capitalization of $658.82M compared with $322.09M for Sanara MedTech (SMTI).
Which stock has performed better over the past year, AVR or SMTI?
AVR returned +38.70% over the past 12 months, compared with +8.41% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Are Anteris Technologies Global and Sanara MedTech in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.